Elizabeth van
Family · Charleston, SCNPI 1891216073
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,129 and has fallen 95.6% since, to $50 in 2023.
Across 101 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$224
- Abbott$189
- Johnson & Johnson$125
- Boehringer Ingelheim$114
- AbbVie$114
- Novartis$103
- plus $765 from 21 others
What the payments were for
- Food & beverage$1,636100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 14 | $224 |
| Abbott | 10 | $189 |
| Johnson & Johnson | 9 | $125 |
| Boehringer Ingelheim | 6 | $114 |
| AbbVie | 8 | $114 |
| Novartis | 6 | $103 |
| Amgen | 6 | $102 |
| AstraZeneca | 7 | $96 |
| Novo Nordisk | 6 | $88 |
| Pfizer | 4 | $67 |
| Lilly USA, LLC | 3 | $48 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Jazz Pharmaceuticals Inc. | 2 | $36 |
| Astellas Pharma US Inc | 2 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Bayer | 2 | $32 |
| Mylan Specialty L.p. | 2 | $30 |
| Nevro Corp. | 1 | $27 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Merck | 1 | $16 |
| Boston Scientific | 1 | $14 |
| Inogen, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Biogen | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
How this compares
$1,636 in reported general payments places this provider in the 75th percentile of 3,248 family providers in South Carolina.
Other family in Charleston
- Gwen ShattuckCharleston$13K
- Amber WardCharleston$12K
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.